Format

Send to

Choose Destination
Health Aff (Millwood). 2009 Nov-Dec;28(6):1666-76. doi: 10.1377/hlthaff.28.6.1666.

Ethical challenges in long-term funding for HIV/AIDS.

Author information

1
Department of Global Health and Social Medicine at Harvard Medical School in Boston, USA. dan_brock@hms.harvard.edu

Abstract

The global response to the AIDS pandemic aims for universal access to treatment and for pursuing every possible avenue to prevention. Skeptics, doubting that the huge increases in current funding levels needed for universal treatment will ever happen, would scale back antiretroviral treatment in favor of more cost-effective preventive interventions. Economics, politics, and science figure in this debate. But there is also a question of ethical principle: Is there a moral imperative to emphasize treatment, even if emphasizing prevention would save more lives? The authors examine moral arguments that address this question, and come down on the side of saving the most lives via prevention.

PMID:
19887407
DOI:
10.1377/hlthaff.28.6.1666
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center